Solbec will fly when phase II trials commence. By that time they will be back in human trials against psoriasis as well so with OD status, cash in the bank, no options overhang and the new MD (with links to Pfizer) at the helm, Solbec will start to show up on the radar of the big boys and they will like what they see.
- Forums
- ASX - By Stock
- SBP
- fda grants orphan drug to coramsine
SBP
solbec pharmaceuticals limited
fda grants orphan drug to coramsine, page-12
Add SBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
Previous Video
Next Video
SPONSORED BY The Market Online